Cell Therapies for Diabetes

When: September 24, 2019, 8:00 am - 5:00 pm
Where: Revere Hotel Boston Common, 200 Stuart Street, Boston, MA

Advance the Clinical Development of Diabetes Cell Therapies by Exploring Techniques to Overcome Immune Rejection and Achieve Scalable Manufacturing Practices to Change Patients’ Lives

Protect Implanted Cells from a Patients’ Alloimmunity and Autoimmunity to Create a Curative Cell Therapy for Diabetes Despite decades of research, diabetes remains a public health challenge of epidemic proportions. The underlying goal in research and therapy has been the restoration of insulin function and normoglycemia. The Cell Therapies for Diabetes Summit is focused on optimizing the clinical and commercial development of these cell therapies with improved manufacturing and streamlined logistical strategies to develop curative therapy to improve the lives of millions of patients worldwide. Bringing together the pioneers of cell therapies for diabetes we will discuss how to develop assays and biomarkers in order to enhance cell characterization to predict clinical translation, and ultimately improve efficacy, providing patients with life-changing therapies. Discuss the membrane microstructure for encapsulation devices to protect implanted cells from a patient’s alloimmunity and autoimmunity. Join us, and leading experts from Novo Nordisk, Nestle, Sanofi, Kadimastem, ViaCyte and Beta O2 as we drive progress towards the future of diabetes care.

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter